pharmaceutical Ingredients market stood at USD11806.93 million in FY2021
and is expected to grow at a CAGR of 12.24% during the forecast period. This
growth can be attributed to high growth of the biopharmaceutical sector in the
country. Additionally, increasing geriatric population in India is further
expected to boost the demand through FY2027. Furthermore, growing prevalence of
chronic diseases such as cardiovascular diseases, diabetes, cancer, respiratory
disorders, among others is going to boost the market. According to the World
Health Organization (WHO), cardiovascular diseases are the leading cause of
death globally, accounting for an estimated 17.9 million lives each year. The major
drivers boosting the growth of the India active pharmaceutical ingredients
market are the rising drug research and increase in development and manufacturing
of drugs and the increasing uptake of biopharmaceuticals. Besides, the sudden
outbreak and spread of COVID-19 pandemic across the globe, with India being
severely hit by the pandemic crisis, also opened opportunities for the growth
of India active pharmaceutical ingredients market. Due to the pandemic spread
major countries boycotted China for trade as it was where the virus originated,
similarly India also banned all kinds of imports and exports with China. This led
to development of manufacturing facilities in the country and improved the
status of domestic players. Also, India being a major pharmaceutical hub
witnessed demand from various countries across the globe for getting the
medical supplies and drugs. This in turn positively influenced the growth of
active pharmaceutical ingredients market in the country. Also, supportive
government policies such as Atmanirbhar Bharat, Pharma Vision 2020, Production
Linked Incentive Scheme, among others is further expected to create lucrative
opportunities for the growth of overall pharmaceutical industry and India
active pharmaceutical ingredients market.
India active pharmaceutical ingredients market is segmented based on method of
synthesis, source, therapeutic application, drug type, company, and region. Based on method of synthesis,
the market is further segmented into synthetic and biological. The synthetic
method of synthesis dominated the market with a share of 56.29% in FY2021 on
account of the easy availability of raw materials and easier process for
development of active pharmaceutical ingredients. While the biological method
of synthesis segment is expected to grow at a rate of 13.21% during the
forecast period owing to the growing demand for vaccines, monoclonal
antibodies, recombinant proteins, biosimilars, among others.
Based on drug type, the
market is further segmented into generics and innovators. Generics dominated
the market with a share of 69.56% in FY2021 as the country also has a large
pool of scientists and engineers with a potential to steer the industry ahead
to greater heights. India ranks 3rd in terms of pharmaceutical production by
volume and 14th by value. The Indian pharmaceutical industry accounts for 2nd
largest number of Abbreviated New Drug Application.
API India Limited, Pfizer Ltd., Ipca Laboratories Limited, Dr. Reddy’s
Laboratories Ltd., Sun Pharmaceutical Industries Limited, Cipla Limited, Lupin
Limited, Aurobindo Pharma Limited, Aarti Drugs Ltd., IOL Chemicals and
Pharmaceuticals Limited, Divis Laboratories Ltd., Granules India Limited,
Laurus Labs Ltd., Solara Active Pharma Sciences, GlaxoSmithKline
Pharmaceuticals Ltd, are some of the major companies operating in the India
active pharmaceutical ingredients market. Major companies are developing
advanced technologies, receiving approvals from regulatory bodies, and
launching new products to stay competitive in the market. Other inorganic
growth strategies include mergers & acquisitions, research collaborations,
joint ventures, and new product developments to sustain themselves amidst
considered for this report:
Historical Years: FY2017-FY2020
Base Year: FY2021
Estimated Year: FY2022E
Forecast Period: FY2023F-FY2027F
Objective of the Study:
- To analyze historical growth in the market size of
India active pharmaceutical ingredients market from FY2017 to FY2021.
- To estimate and forecast the market size of India active
pharmaceutical ingredients market from FY2022 to FY2027 and growth rate
- To classify and forecast India active
pharmaceutical ingredients market based on method of synthesis, source, therapeutic
application, drug type, company, and regional distribution.
- To identify dominant region or segment in the
India active pharmaceutical ingredients market.
- To identify drivers and challenges for India active
pharmaceutical ingredients market.
- To examine competitive developments such as
expansions, new product launches, mergers & acquisitions, etc., in
India active pharmaceutical ingredients market.
- To identify and analyze the profiles of leading
players operating in India active pharmaceutical ingredients market.
- To identify key sustainable strategies adopted by
market players in India active pharmaceutical ingredients market.
Click here to download the sample
TechSci Research performed
both primary as well as exhaustive secondary research for this study.
Initially, TechSci Research sourced a list of manufacturers across the country.
Subsequently, TechSci Research conducted primary research surveys with the identified
companies. While interviewing, the respondents were also enquired about their
competitors. Through this technique, TechSci Research could include the
manufacturers which could not be identified due to the limitations of secondary
research. TechSci Research analyzed the manufacturers, distribution channels
and presence of all major players across the country.
TechSci Research calculated the market
size of India active pharmaceutical ingredients market using a bottom-up
approach, wherein data for various end-user segments was recorded and forecast
for the future years. TechSci Research sourced these values from the industry
experts and company representatives and externally validated them through
analyzing historical data of these segments for getting an appropriate, overall
market size. Various secondary sources such as company websites, news articles,
press releases, company annual reports, investor presentations and financial
reports were also studied by TechSci Research.
Pharmaceutical Ingredients manufacturers/ suppliers/ distributors
research and consulting firms
bodies such as regulating authorities and policy makers
forums and alliances related to Active Pharmaceutical Ingredients
The study is useful in providing answers
to several critical questions that are important for the industry stakeholders
such as manufacturers, suppliers and partners, end users, etc., besides
allowing them in strategizing investments and capitalizing on market
In this report, India Active
Pharmaceutical Ingredients market has been segmented into following
categories, in addition to the industry trends which have also been detailed
Active Pharmaceutical Ingredients Market, By Method of Synthesis:
Active Pharmaceutical Ingredients Market, By Source:
- Contract Manufacturing Organizations
Active Pharmaceutical Ingredients Market, By Therapeutic Application:
- Cardiovascular Diseases
- Anti-diabetic Drugs
- Oncology Drugs
- Neurological Disorders
- Musculoskeletal Disorders
Active Pharmaceutical Ingredients Market, By Drug Type:
- India Active
Pharmaceutical Ingredients Market, By Region:
Profiles: Detailed analysis of the major companies present in India Active
Pharmaceutical Ingredients market.
With the given market data, TechSci
Research offers customizations according to a company’s specific needs. The
following customization options are available for the report:
analysis and profiling of additional market players (up to five).